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Fontan Operation: A 
Comprehensive Review
P. Syamasundar Rao
Abstract
Since the first description of the Fontan operation in the early 1970s, a number 
of modifications have been introduced and currently staged, total cavopulmonary 
connection with fenestration has become the most commonly used multistage 
surgery in diverting the vena caval blood flow into the lungs. The existing ventricle, 
whether it is left or right, is utilized to supply systemic circuit. During Stage I, 
palliative surgery is performed, usually at presentation in the neonatal period/early 
infancy, on the basis of pathophysiology of the cardiac defect. During Stage II, a 
bidirectional Glenn procedure is undertaken in which the superior vena caval flow 
is diverted into the lungs at an approximate age of 6 months. During Stage IIIA, 
the blood flow from the inferior vena cava (IVC) is rerouted into the pulmonary 
arteries, typically by an extra-cardiac conduit along with a fenestration, generally 
around 2 years of age. During Stage IIIB, the fenestration is closed by transcatheter 
methodology 6–12 months after Stage IIIA. The evolution of Fontan concepts, the 
indications for Fontan surgery, and the results of old and current types of Fontan 
operation form the focus of this review.
Keywords: Fontan operation, bidirectional Glenn procedure, modified Blalock-
Taussig shunt, pulmonary artery banding, Norwood procedure, Sano shunt, extra-
cardiac conduit, fenestrated Fontan, tricuspid atresia, double-inlet left ventricle, 
hypoplastic left heart syndrome, unbalanced atrioventricular septal defect
1. Introduction
Following the initial description of the physiologically corrective operation 
for tricuspid atresia by Fontan and Baudet [1] and Kreutzer and his associates 
[2] almost simultaneously, such surgery was widely adapted by most pediatric 
cardiologists and pediatric cardiac surgeons. This concept of bypassing the right 
ventricle (RV) was further extended to manage other cardiac defects with a 
functionally single ventricle.
The original surgery as described by Fontan and Baudet [1] consisted of (1) 
end-to-end anastomosis of superior vena cava (SVC) with the right pulmonary 
artery (PA) (classical Glenn procedure [3]), (2) connection of the separated 
right PA to the right atrium (RA) either directly or through an aortic homograft, 
(3) closure of the defect in the atrial septum, (4) insertion of a pulmonary valve 
homograft into the orifice of the inferior vena cava (IVC), and (5) ligation of the 
main PA, to entirely bypass the RV. On the basis of the procedures performed, one 
must infer that Fontan’s concept was to use the right atrium as a pumping chamber; 
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therefore, he inserted a prosthetic valve into the IVC and right atrial-pulmonary 
artery junction.
On the contrary, Kreutzer et al. [2] anastomosed the right atrial appendage to 
the PA directly or by a pulmonary homograft and closed the ASD. Neither a Glenn 
procedure was performed nor a prosthetic valve was inserted in the IVC. Kreutzer’s 
view appears to be that the RA does not function as a pump and that the left 
ventricle functions as a suction pump in the system.
The surgical procedure as generally performed appears to shadow Kreutzer’s 
principle, and consequently, I have used the term “Fontan-Kreutzer operation” 
to describe this procedure [4–8]. However, because of priority of publication and 
more common usage in the literature, I will use the term “Fontan operation” in this 
chapter.
In this review, I will discuss the evolution of the Fontan concepts, the indications 
for Fontan operation, the Fontan procedure as used currently, and the results of old 
and current types of Fontan.
2. Evolution of the Fontan operation
A number of modifications of the aforementioned surgery were made by these 
[1, 2] and other groups of investigators [9, 10] in the field. In this section, these 
concepts/procedures will be reviewed.
2.1 Initial surgical modifications
During the first 20 years after Fontan’s [1] and Kruetzer’s [2] description of the 
procedure, a number of modifications of the surgery were undertaken by several 
surgeons, as extensively reviewed and referenced elsewhere [9, 10]. In general, 
there was a consensus that there is no need for a classic Glenn anastomosis and 
that a prosthetic valve is not necessary in the IVC. Detailed review of these papers 
revealed that four major types of Fontan operations were being performed for 
physiologic correction of tricuspid atresia. These include (1) RA-PA anastomosis, 
direct or through a non-valved conduit; (2) RA-PA anastomosis through a valved 
conduit; (3) RA-RV anastomosis, direct or non-valved anastomosis; and (4) RA-RV 
anastomosis through a valved conduit.
In order to understand the advantages of one operation over the other, 17 
papers published as of December 1990 that have documented adequate informa-
tion to evaluate mortality and reoperation rates for each of the four types of 
Fontan surgery were reviewed. Pooled data from these 17 articles and statistical 
comparisons were presented in Tables I–IV for the interested reader [9]. This 
analysis revealed that atriopulmonary (RA-PA) connection appears to be better 
than atrioventricular (RA-RV) anastomosis and direct connection is better than 
valved or non-valved conduit anastomosis. Nevertheless, atrioventricular valved 
(homograft) conduit anastomosis appears to have advantages of (1) restoring a 
four-valved, four-chambered, biventricular heart and (2) lower right atrial pressure 
than with atriopulmonary connection. Based on these data [9, 10], the following 
conclusions were drawn: (1) direct atriopulmonary connection for children with 
tricuspid atresia with normally related great arteries and a small (<30% of normal) 
right ventricle without trabecular right ventricular component and for patients who 
had tricuspid atresia with transposition of the great arteries and (2) atrioventricular 
valved (homograft) conduit anastomosis for patients with tricuspid atresia and 
normally related great arteries but with a right ventricular size greater than 30% of 
normal and a trabecular right ventricular component [9, 10].
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2.2 Other developments
2.2.1 Bidirectional Glenn procedure (cavopulmonary anastomosis)
Bidirectional cavopulmonary anastomosis is a modified version of classic Glenn 
procedure in which the upper end of the divided SVC is anastomosed end to side 
to the right PA without disconnecting the latter from the main PA. Thus, the SVC 
blood is diverted into both the right and left PAs, justifying the term, “bidirectional.”
Experimental bidirectional cavopulmonary anastomosis was first studied 
by Haller et al. [11] in animal models, and its first clinical use was described 
by Azzolina et al. [12] in 1972. Other investigators [13–17] later applied this 
technique to palliate complex heart defects with decreased pulmonary blood flow. 
Hemodynamic advantages of the bidirectional Glenn procedure are improvement 
of effective pulmonary blood flow, decrease in total pulmonary blood flow, and 
reduction of left ventricular volume overloading. In addition, preservation of 
continuity of the pulmonary artery is an added advantage and may help facilitate 
a low-risk Fontan procedure. When both right and left SVCs are present, bilateral 
bidirectional Glenn shunts should be performed, especially if the bridging 
innominate vein is absent or small. Based on our own experience and that 
published in the literature [13–17], the author recommended serious consideration 
in employing bidirectional cavopulmonary anastomosis as an interim palliative 
procedure for patients who are at an increased risk for the Fontan procedure [9, 10].
2.2.2 Lateral tunnel
Puga et al. [18] positioned a patch inside the right atrium to divert the IVC blood 
into the PAs; they had good results in the 12 patients that they used this technique. 
This was later called lateral tunnel and was widely used until extra-cardiac conduits 
came into vogue.
2.2.3 Total cavopulmonary connection
To better understand the valve-less atriopulmonary anastomosis type of Fontan, 
de Leval et al. [19] performed hydrodynamic studies and found that (1) the right 
atrium is not an efficient pump in non-valved atriopulmonary connections, (2) 
pulsations in a non-valved circulation truly generate turbulence with consequent 
decrease in net flow, and (3) energy losses occur in the non-pulsatile chambers, 
corners, and obstructions. In an attempt to address these deficiencies, they 
developed a procedure which they named “total cavopulmonary connection.” In 
this procedure, they connected the divided SVC, end to side, to the undivided right 
pulmonary artery (bidirectional Glenn), and the IVC blood is diverted through 
a composite intra-atrial tunnel (with the use of posterior wall of the right atrium 
as posterior wall of the tunnel) into the cardiac end of the divided superior vena 
cava, which in turn was connected to the PA. They felt that technical simplicity, 
maintenance of low right atrial and coronary sinus pressure, and reduction of 
risk of atrial thrombus formation are advantages of this type of operation. They 
performed this procedure on 20 patients and observed two early deaths and one late 
death. Postoperative hemodynamic studies were performed in 10 of the survivors 
which indicated good results. They recommended this type of operation for patients 
with a non-hypertrophied right atrium. While the total cavopulmonary connection 
was initially devised for patients with complex atrial anatomy and/or systemic 
venous anomalies, it has since been used extensively for all types of cardiac anatomy 
with one functioning ventricle and irrespective of venous anomalies.
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Subsequent experimental studies by Sharma and his associates [20] indicated 
that complete or minimal offset between the orifices of the SVC and IVC into the 
right pulmonary artery decreases energy losses.
2.2.4 Extra-cardiac conduit
Marcelletti et al. [21, 22] used an interposition extra-cardiac conduit from the 
IVC to the PA in place of lateral tunnel used in total cavopulmonary connection 
in 1990. Subsequently, most surgeons adopted this modification of total cavopul-
monary connection, and currently extra-cardiac conduits are used in most Fontan 
operations.
2.2.5 Staged Fontan
Since the vast majority of patients requiring Fontan operation present as 
neonates or in the early infancy, palliative procedures are performed at the time 
of presentation, and subsequently (at 12–18 months of age) the Fontan operation 
is undertaken. A considerable mortality (~16%) was seen with primary Fontan 
surgery, largely related to the impact of rapid changes in ventricular geometry and 
development of ventricular diastolic dysfunction. The concept of further staging 
the procedure by performing bidirectional Glenn procedure around 6 months of age 
followed by final Fontan between 12 and 18 months of age was introduced in early 
1990s [23, 24]. Performing the Fontan procedure in stages appears to decrease over-
all mortality, most likely related to improving the ventricular function by correction 
of the afterload mismatch that is associated with one-stage Fontan procedure. 
At the current time, most centers prefer staged Fontan with bidirectional Glenn 
initially, followed later by extra-cardiac conduit diversion of the inferior vena caval 
blood into the PA.
2.2.6 Fenestrated Fontan operation
In 1978, Choussat et al. proposed several criteria for performing Fontan opera-
tion [25]. Many cardiologists and surgeons have modified these criteria. Patients 
not meeting these criteria were deemed to be at a higher risk for a poor prognosis 
following a Fontan operation than patients who are within the limits of the set 
criteria. For the high-risk group, several investigators have proposed the concept 
of leaving a small atrial septal defect (ASD) open to facilitate decompression of the 
right atrium [26–28]. Laks et al. advocated closure of the atrial defect by constrict-
ing the preplaced suture in the postoperative period [28], while Bridges et al. [27] 
used a transcatheter closure method at a later date.
Higher cardiac output and significant decreases in the postoperative pleural 
effusions and systemic venous congestion were noted after a fenestrated Fontan 
procedure. In addition, the duration of hospitalization appears to have decreased. 
Nonetheless, these beneficial effects are at the expense of mild arterial hypoxemia 
and potential for paradoxical embolism.
While the fenestrated Fontan procedure was initially designed for patients 
at high risk for Fontan surgery, it has since been used in patients with modest or 
even low risk. Although rare, reports of cerebrovascular or other systemic arterial 
embolic events occurring after a fenestrated Fontan operation tend to contra-
indicate the use of fenestrations in patients with low or usual risk. In following 
years, fenestrated Fontan have been routinely used at most institutions. Some data 
indicate that routine fenestration is not necessary [29].
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2.2.7 Device closure of Fontan fenestration
Patients who have undergone a fenestrated Fontan operation or patients who 
have a residual atrial defect, despite correction, may have clinically significant 
right-to-left shunt causing varying degrees of hypoxemia. These residual defects 
should be closed not only to address arterial desaturation but also for prevention of 
paradoxical embolism [30, 31]. Although two types of fenestration closure, namely, 
constriction of the preplaced suture in the postoperative period [26, 28] and device 
closure later [27] were described, device closure is opted at most institutions. 
Closure of such defects can be performed by using transcatheter techniques 
[32–35]. The procedure is usually performed 6–12 months following fenestrated 
Fontan procedure. Although a number of devices have been used in the past 
[32–35], at the present time, Amplatzer septal occluders are the most commonly 
used devices to accomplish such closures.
3. Indications for Fontan operation
The indications for opting for a Fontan operation are patients who have one 
functioning ventricle. At first, patients with tricuspid atresia were selected for this 
procedure [1, 2]. Shortly thereafter, patients with double-inlet left (single) ventricle 
were added to the indications for Fontan [36]. Following description of surgical 
palliation of hypoplastic left heart syndrome (HLHS) by Norwood et al. [37, 38] 
in the early 1980s, HLHS became the major lesion requiring Fontan operation. 
Subsequently, mitral atresia (with normal aortic root), unbalanced atrioventricular 
septal defects (AVSDs), pulmonary atresia with intact ventricular septum with 
markedly hypoplastic right ventricle, and other complex heart defects with one 
functioning ventricle were selected for Fontan surgery.
Attempts to insert prosthetic ventricular septum for single ventricle patients met 
with problems, leading to abandoning such procedures. Thereafter, Fontan became 
a preferred treatment method. With reasonably good results of Fontan, the pen-
dulum swung so that any patient who could not undergo complete repair became a 
candidate for Fontan.
A middle of the road method, the so-called one-and-one-half ventricle repair 
was developed for patients with pulmonary atresia with intact ventricular septum 
with modest-sized right ventricle. In this procedure, a bidirectional Glenn pro-
cedure to divert the SVC flow into the PA is performed and allows the small right 
ventricle to pump the IVC blood into the pulmonary circuit, and the patent fora-
men ovale is closed. It is generally considered to be a better option than Fontan, 
although, to my knowledge, there are no comparative studies to assess this issue.
Because of relatively high mortality rates (17.0–31.7%) [39, 40] and low actuarial 
survival rates (66.5% at 5 years and 64.4% at 15 years) [41] for unbalanced AVSD 
patients following Fontan, a number of institutions attempted single stage or staged 
biventricular repair or conversion from single ventricle (Fontan) to biventricular 
repair [39, 42–47]. Detailed analysis by Nathan et al. [39] suggested that the 
biventricular repair and conversion from single ventricle (Fontan) to biventricular 
repair groups had reasonably similar mortality rates and a similar need for cardiac 
transplantation, but these parameters were lower than those seen in the Fontan 
palliation cohort.
Cardiac transplantation is a surgical alternative in the management of 
HLHS [48] and other single ventricle lesions. While heart transplantation was 
used at several institutions initially for HLHS, because of non-availability of 
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donor hearts, most institutions have reverted to the Norwood/Fontan route. In 
addition, following successful cardiac transplantation, multiple medications 
for the prevention of graft rejection, frequent outpatient visits and periodic 
endomyocardial biopsy, to recognize rejection very early, are necessary in the 
management of these children. At the present time, cardiac transplantation is used 
for patients failing Fontan operation at a limited number of institutions.
4. Current status of Fontan operation
As reviewed above, since the original description in the early 1970s, the Fontan 
procedure has undergone numerous modifications, and, at the present time it is best 
described as staged total cavopulmonary connection (TCPC) with an extra-cardiac 
conduit and fenestration. It is performed in three stages.
4.1 Stage I
The majority, if not all, of patients who require Fontan operation (see Section 3. 
Indications for Fontan Operation) present during the neonatal and early infancy 
period, and the Fontan cannot be performed at that time because of naturally high 
PA pressure and high pulmonary vascular resistance (PVR). Therefore, Fontan, by 
necessity, becomes a multistage procedure. These babies should receive palliative 
intervention to allow them to reach the age and size to undergo successful Fontan 
surgery. The type of palliation is largely dependent upon the hemodynamic 
disturbance produced by multiple defects associated with a given congenital heart 
defect (CHD).
4.1.1 Decreased pulmonary blood flow
In neonates with decreased pulmonary blood flow, the ductus arteriosus should 
be kept open by administration of prostaglandin E1 (PGE1) intravenously at a dose 
of 0.05–0.1 mcg/kg/min. Once the O2 saturation improves, the dosage of PGE1 is 
gradually reduced to 0.02–0.025 mcg/kg/min to minimize the side effects of the 
prostaglandins. Following stabilization and diagnostic studies, as necessary to 
confirm the diagnosis, a more permanent way of providing pulmonary blood flow 
should be instituted. A number of methods to augment pulmonary blood flow have 
been used over the years [49, 50]. These include subclavian artery to ipsilateral 
PA anastomosis (classic Blalock-Taussig shunt), descending aorta to the left PA 
anastomosis (Potts shunt), ascending aorta to the right PA anastomosis (Waterston-
Cooley shunt), SVC to right PA anastomosis, end-to-end (classic Glenn shunt), 
enlargement of the ventricular septal defect (VSD), formalin infiltration of the 
wall of the ductus arteriosus, central aortopulmonary fenestration or expanded 
polytetrafluoroethylene (Gore-Tex; W. L. Gore and Associates, Inc., Newark, 
Delaware) shunt, Gore-Tex interposition graft between the subclavian artery and the 
ipsilateral PA (modified Blalock-Taussig shunt), balloon pulmonary valvuloplasty, 
and stent implantation into the ductus arteriosus. Currently modified Blalock-
Taussig (BT) shunt [51] by insertion of a Gore-Tex graft between the subclavian 
artery to the ipsilateral PA (Figure 1a) is performed by most surgeons to address 
pulmonary oligemia. More recently connecting the RV outflow tract with the PA via 
non-valve Gore-Tex graft is being used at several institutions to palliate pulmonary 
oligemia. Placement of a stent in the ductus arteriosus [52–54] and balloon 
pulmonary valvuloplasty (if the predominant obstruction is at the pulmonary valve 
level) [55–57] are other available options to augment the pulmonary blood flow.
7Fontan Operation: A Comprehensive Review
DOI: http://dx.doi.org/10.5772/intechopen.92591
4.1.2 Increased pulmonary blood flow
In babies with increased pulmonary blood flow, optimal anti-congestive 
measures should be started immediately. Once the congestive heart failure (CHF) 
is adequately addressed, PA banding (Figure 1b) is performed [58] irrespective of 
control of CHF.
4.1.3 Normal pulmonary blood flow
Infants with near normal pulmonary blood flow with O2 saturations in the low 
80s do not need intervention and are clinically followed until Stage II.
4.1.4 Hypoplastic left heart syndrome
Neonates with hypoplastic left heart syndrome usually have Norwood palliation 
(Figure 2) [37, 59] in the neonatal period; in this operation, the following 
procedures are performed: (1) the main pulmonary artery and the aorta are 
anastomosed together; additional prosthetic material is used as needed; (2) the 
pulmonary circulation receives blood supply by connecting the aorta to the PA 
via a modified BT shunt [51] (Figure 2b); (3) atrial septum is excised to allow 
unhindered blood flow from the left to the atrium; and (4) ductal tissue is removed, 
and coarctation of the aorta, if present is repaired. Some surgeons use alternative 
Sano shunt [60], connecting the RV outflow tract to the PA (Figure 2c) instead of 
BT shunt.
4.1.5 Address other defects during Stage I
In patients with inter-atrial obstruction, it should be relieved either by 
transcatheter methodology or by surgery as deemed appropriate for a given clinical 
scenario. If there is associated coarctation of the aorta, it should also be relieved. 
Some patients with double-inlet left ventricle may have significant obstruction at 
the level of bulboventricular foramen [61]. Similarly some babies with tricuspid 
Figure 1. 
Stage I Fontan. Selected frames form cineangiograms in two different babies; the first with pulmonary oligemia 
who received Blalock-Taussig (BT) shunt (a) and the second with pulmonary plethora who had pulmonary 
artery banding (PB) (b). C, catheter; LPA, left pulmonary artery; RPA, right pulmonary artery (Reproduced 
from [30]).
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atresia with transposition of the great arteries may have obstruction at the VSD 
level, causing obstruction to systemic blood flow [61, 62]. Such babies require 
Damus-Kaye-Stansel (connection of the aorta to the PA) [63] along with a BT 
shunt. Inter-atrial obstruction may be present frequently in babies with mitral 
atresia and single ventricle [64]. In such babies, predictable fall in PVR occurs 
following balloon or surgical relief of inter-atrial obstruction [64]; consequently, 
PA banding should be undertaken without hesitation at the time of relieving the 
atrial septal obstruction, so as to reduce the probability for CHF, lower the PVR and 
PA pressure, prevent pulmonary vascular obstructive disease (PVOD), and pave the 
way for Fontan approach [64].
4.2 Stage II
Irrespective of the type of palliative surgery in the neonatal period, 
bidirectional Glenn procedure [12–14, 17, 23], namely, anastomosis of the SVC 
to the right PA, end-to-side (Figure 3) is performed around the age of 6 months. 
The previously performed BT or Sano shunt is ligated at the same time. Although 
performing the procedure at 6 months is generally adopted, it can be performed 
as early as 3 months provided normalcy of PA pressure and anatomy can be 
documented.
Figure 2. 
Stage I Fontan for hypoplastic left heart syndrome. Selected frames from cineangiograms demonstrating Norwood 
operation in which the neoaorta (NAo) and hypoplastic aorta (HAo) perfuse the coronary arteries (CAs) as 
shown in (a), Blalock-Taussig (BT) shunt as illustrated in (b) and Sano shunt as depicted in (c). (b) and (c) are 
from two different babies. LPA, left pulmonary artery; RPA, right pulmonary artery (Reproduced from [30]).
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In patients with persistent left SVC, bilateral bidirectional Glenn (Figure 4) 
is undertaken especially in patients with a small or absent left innominate vein. A 
bidirectional Glenn procedure may also be performed for patients with infrahepatic 
interruption of the IVC with azygos or hemiazygos continuation, and such a 
procedure is called a Kawashima procedure by some authorities.
Prior to the bidirectional Glenn procedure, normal PA pressures and 
adequate size of the branch PAs should be ensured by cardiac catheterization and 
Figure 3. 
Stage II of Fontan. Selected frames from cineangiograms in two different children illustrating bidirectional 
Glenn operation in which the superior vena cava is anastomosed to the right pulmonary artery (RPA). 
Unobstructed flow from the SVC to the right (RPA) and left (LPA) pulmonary arteries is clearly seen. 
(Reproduced from [30]).
Figure 4. 
Stage II Fontan. Selected frames from cineangiograms in a different child than shown in Figure 3, illustrating 
bilateral bidirectional Glenn operation. (a) Superior vena caval angiogram demonstrates immediate 
visualization of the right pulmonary artery (RPA). Un-opacified blood flow from persistent left SVC 
(PLSVC) is indicated by the arrow in (a). (b) PLSVC angiogram illustrates rapid opacification of the left 
pulmonary artery (LPA). Un-opacified blood from the right SVC is shown by the arrow in (b). Flow from the 
respective SVCs into the pulmonary arteries is clearly seen (Reproduced from [30]).
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cineangiography. Echo-Doppler or other imaging studies (magnetic resonance 
imaging [MRI] or computed tomography [CT]) is advocated at some institutions.
If PA stenosis is present, it may be addressed with balloon angioplasty or stent 
implantation, as deemed appropriate, or it may be addressed during the bidirec-
tional Glenn procedure. Atrioventricular valve regurgitation, aortic coarctation, 
subaortic obstruction, and other abnormalities should also be repaired/addressed at 
the time of this operation.
4.3 Stage III
During the final Stage III, the IVC flow is diverted into the PA along with cre-
ation of a fenestration. We arbitrarily divided [30] these procedures into Stage IIIA 
(diversion of IVC into the PA) and Stage IIIB (closure of the fenestration).
4.3.1 Stage IIIA
In the final Stage III, the total cavopulmonary connection is achieved by diverting 
the IVC flow into the PA either by a lateral tunnel [18, 65] or by an extra-cardiac, 
non-valved conduit (Figures 5 and 6) [21, 22]; the procedure is usually performed 
between the ages of 1 and 2 years, usually 1 year following the bidirectional Glenn 
procedure. Most surgeons seem to prefer extra-cardiac conduit to accomplish this 
final stage of Fontan. The majority of surgeons construct a fenestration, 4–6 mm in 
size, between the conduit and the atria (Figures 5 and 6) [27]. While the creation 
of fenestration during the Fontan operation was initially proposed for high-risk 
patients [27, 28], most surgeons now seem to prefer fenestration, since fenestration 
during the Fontan improves mortality rate and reduces morbidity during the 
immediate postoperative period [30].
Cardiac catheterization and selective cineangiography are usually performed 
shortly prior to Fontan conversion in order to assess the PA anatomy and pressures, 
trans-pulmonary gradient, PVR, and ventricular end-diastolic pressure and 
Figure 5. 
Selected cine frames in posteroanterior (a) and lateral (b) views, demonstrating Stage IIIA Fontan procedure 
diverting the inferior vena caval flow into the pulmonary arteries via a non-valve conduit (Cond). Flow across 
the fenestration (fen) is shown by arrows in (a) and (b). HV, hepatic veins; LPA, left pulmonary artery; PG, 
pigtail catheter in the descending aorta; RPA, right pulmonary artery.
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to assure that they are normal prior to proceeding with Fontan completion. At 
some institutions, MRI is used for this assessment instead of catheterization 
and angiography; however, the author’s preference is catheterization. During 
this catheterization, any significant collateral vessels that are present are also 
transcatheter-occluded by most cardiologists.
4.3.2 Stage IIIB
In the final stage, Stage IIIB, the fenestration is closed (Figures 7b, 8b, and 
9B and C) by transcatheter methodology [27, 30–35], usually 6–12 months after 
Fontan Stage, IIIA. In the past, most devices used to occlude ASDs [32–35] were 
employed for this purpose, but at the present time, Amplatzer septal occluders are 
the most commonly used devices to accomplish such closures. If there are any other 
residual shunts, they should also be occluded (Figure 10) by device closure.
4.4 Interstage problems
In children who have one functioning ventricle requiring Fontan correction, the 
systemic and pulmonary circulations work in-parallel in place of the usual in-series 
circulation. A fragile equilibrium between the two circulations must be preserved so 
that adequate systemic and pulmonary perfusions are maintained. There is substantial 
interstage mortality ranging from 5 to 15% [66–68] which may be due to restrictive 
atrial communication, obstruction of the aortic arch, blockage of the shunt, distortion 
of the PAs, atrioventricular valve insufficiency, or a combination thereof [66]. 
Intercurrent illnesses such as dehydration, respiratory tract illness, or fever disturb 
this balance and make the patients to become critically ill and have been blamed for 
interstage mortality [66, 68]. The surgically created BT and Sano shunts may also get 
thrombosed producing severe hypoxemia [69]. Indeed, these abnormalities produce 
significant interstage mortality [67]; these appear to occur more frequently between 
Stages I and II than between Stages II and III. Consequently, extreme vigilance in 
managing these patients should be maintained by the caregiver [68, 70]; even trivial 
illnesses must be aggressively monitored and addressed as appropriate.
Figure 6. 
Selected cine frames in posteroanterior (a) and lateral (b) views in a different patient to the one shown in 
Figure 5, demonstrating Stage IIIA Fontan procedure diverting the inferior vena caval (IVC) flow into the 
pulmonary arteries via a non-valve conduit (Cond). Flow across the fenestration (fen) is shown by arrows in 
(a) and (b). Abbreviations are the same as those in Figure 5.
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5. Results of Fontan operation
Immediate and follow-up results of both older and current types of Fontan will 
be reviewed in this section.
Figure 8. 
Stage IIIB. (a) Selected frames from cineangiograms in lateral view of the same patient illustrated in Figure 5 
showing Stage IIIA of the Fontan operation in which the inferior vena caval (IVC) flow is diverted into the 
pulmonary arteries by a non-valve conduit (Cond). The fenestration (fen) is shown by the arrow in (a). 
(b) Closure of the fenestration with an Amplatzer septal occluder device (D) is shown with an arrow in (b). 
(Stage IIIB). Reproduced from [30].
Figure 7. 
Stage IIIB. (a) Selected frames from cineangiograms in anteroposterior projection illustrating Stage IIIA of 
the Fontan operation in which the inferior vena caval (IVC) flow is diverted into the pulmonary arteries by a 
non-valve conduit (Cond). The fenestration (fen) is shown by the arrow in (a). (b) Closure of the fenestration 
with an Amplatzer septal occluder device (D) is shown with an arrow in (b). HV, hepatic veins; LPA, left 
pulmonary artery; RPA, right pulmonary artery (Reproduced from [30]).
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5.1 Immediate results
The results of original Fontan [1, 2] and its earlier modifications, namely, 
RA-to-PA or RA-to-RV anastomosis either directly or via valved or non-valved 
conduits, revealed high initial mortality rates. The initial mortality rates ranged 
from 10 to 26% [9, 10, 71, 72]. Furthermore, the postoperative stay in the intensive 
care setting was prolonged.
The initial mortality following staged, total cavopulmonary connection has 
decreased remarkably [73–78]. Patients who had total cavopulmonary connection 
Figure 9. 
(A) Selected cine frame from a Fontan conduit cineangiogram in anteroposterior view, demonstrating tubular 
fenestration (Tu fen) with opacification of the left atrium (LA). (B) The Tu fen is closed with an Amplatzer 
vascular plug (AVP). (C) A follow-up conduit cineangiogram after AVP implantation, showing complete 
occlusion of the Tu fen. TEE, transesophageal probe.
Figure 10. 
(A) A selected cineangiographic frame showing the Fontan conduit in lateral view, demonstrating a residual 
shunt (RS) at the superior aspect of the conduit (Cond). (B) The RS was occluded with an Amplatzer septal 
occluder device (AD); the residual shunt is no longer seen. TEE, transesophageal echo probe.
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without fenestration had initial mortality rates ranging from 8 to 10.5% [73–75], 
while subjects who had total cavopulmonary connection with fenestration had 
slightly lower (4.5–7.5%) initial mortality rates [76–78].
In one large single institutional study examining the results of 500 consecu-
tive Fontan surgery patients [77], early failure was associated with high (≥19 mm 
Hg) mean PA pressure, young age at surgery, heterotaxy syndrome, a right-sided 
tricuspid valve as systemic atrioventricular valve, distorted pulmonary arteries, an 
atriopulmonary connection, no Fontan fenestration, and longer cardiopulmonary 
bypass time.
These investigators also observed that a significant improvement in morbidity 
and mortality from early (first quartile—early failures: 27.1%) to the more recent 
time (last quartile—early failures: 7.5%) occurred [77]. This progress appears to 
be related to increasing surgical and intensive care experience as well as to more 
recently introduced Fontan modifications.
5.2 Follow-up results
Long-term follow-up results were also poor with older types of Fontan [9, 10]. 
The late mortality rates varied from 1 to 11%, and when early and late mortality 
rates were combined, they varied between 11 and 25%. The need for reoperations 
was present in 1–11% of patients. Factors adversely influencing late mortality and 
reoperation rates are earlier calendar year of operation, age of patient at the time of 
surgery, type of prior palliative procedures, hypoplasia, distortion or obstruction 
of PAs, subaortic obstruction, significant mitral valve insufficiency, elevated PA 
pressure or resistance, decreased left ventricular function, increased left ventricular 
muscle mass, asplenia syndrome, and others [9, 10].
Following the introduction of staged cavopulmonary anastomosis (both 
lateral tunnel and extra-cardiac conduit diversion of IVC blood to the PA), the 
long-term outcomes have improved. In one study in which results of follow-up 
for 10.2 ± 0.6 years of 196 patients were examined, the estimated Kaplan-
Meier survival was 93 and 91% at 5 and 10 years, respectively [79]. An equally 
impressive finding was freedom from supraventricular arrhythmias in 96 and 91% 
of patients at 5 and 10 years following surgery. In a different study, the actuarial 
survival 15 years following surgery was 85% [80]. But, late re-interventions were 
necessary in 12.7% of patients. When lateral tunnel and extra-cardiac conduit 
types of Fontan were compared, the outcomes were found to be similar for both 
groups [81, 82].
Using fenestration during Fontan appears to improve early mortality and 
morbidity, particularly demonstrated in high-risk patents [83]. A more recent 
analysis in a smaller group of patients did not demonstrate significant advantage of 
fenestrated Fontan over the non-fenestrated [84]. However, the general consensus 
is that using fenestration during Fontan decreases mortality and morbidity during 
the postoperative period [30, 76–78].
6. Follow-up protocol and complications
Periodic follow-up following Fontan is generally recommended. These patients 
are evaluated at 1, 6, and 12 months after Stage IIIB (device closure of fenestration) 
and yearly thereafter. During the follow-up, platelet-inhibiting doses of aspirin 
2–5 mg/kg/day in children or clopidogrel 75 mg/day in adults to prevent thrombus 
formation and angiotensin-converting enzyme inhibitors for afterload reduction 
are generally prescribed. Electrocardiograms and echocardiograms are generally 
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performed during evaluation of these patients with additional imaging studies, as 
indicated. Any abnormalities, as and when detected, are addressed.
During follow-up, a number of complications were reported, and these include 
arrhythmias, obstructed Fontan pathways, cyanosis, paradoxical emboli, thrombi, 
development of collateral vessels, and protein loosing enteropathy [30, 31, 85]. 
These complications appear to be more frequent with older types of Fontan than 
with the currently used staged, total cavopulmonary connection with extra-cardiac 
conduit and fenestration. When such complications develop, they should be 
promptly investigated and treated. In the ensuing paragraphs, a brief review of 
some of these complications will be presented.
6.1 Arrhythmias
Arrhythmias were more frequently seen in patients with old Fontan 
(atriopulmonary connection) than with staged TCPC. The observed arrhythmias 
were typically atrial arrhythmias, namely, atrial flutter/fibrillation and 
supraventricular tachycardia. Initially, anti-arrhythmic medications are used to 
control the rhythm disturbance. This should be followed by hemodynamic and 
angiographic assessment to identify obstructive lesions in the Fontan pathways. 
The obstructive lesions should be treated with balloon angioplasty, stent, or 
surgery, as applicable. Continued rhythm abnormality calls for radiofrequency 
ablation. Although the success rate of radiofrequency ablation is high in 80% range 
[86], rates of recurrence range from 30 to 40%. In subjects who have resistant 
arrhythmias, reducing the atrial mass, switch to TCPC with concomitant Maize 
procedure is advisable [87]. A few patients develop atrioventricular block or 
sick sinus syndrome which may require pacemaker implantation. Fortunately, 
ventricular arrhythmias are less frequent.
6.2 Development of obstruction in Fontan pathways
Obstructions in Fontan circulation may occur. Obstructive lesions in the SVC 
or IVC may arise but are less frequently seen. However, branch pulmonary artery 
stenoses may be seen more often. Obstructions within the lateral tunnel or extra-
cardiac conduit are also uncommon, but may occur due to thrombus formation 
and will be addressed in the section on “Thrombus formation.” In the presence 
of signs and symptoms indicative of obstruction in the Fontan pathway, prompt 
investigation to confirm such obstruction should be made. While echo studies are 
useful in young children, poor echo windows in adolescents and adults may require 
MRI and CT, and/or angiographic studies to confirm or exclude such obstructive 
lesions. If the obstructive lesions are detected, they should be promptly relieved by 
balloon angioplasty or stent implantation (Figure 11) [88]. Surgery may be needed 
in rare occasions.
6.3 Residual arterial desaturation and paradoxical emboli
Sometimes connections between lateral tunnel and extra-cardiac conduit 
on the one hand and the atrium on the other persist. These residual defects and 
intentionally created Fontan fenestrations result in right-to-left shunt because 
the pressure in the Fontan conduit is higher than that of the atrial pressures. 
These residual defects will result in arterial desaturation and may become the site 
of paradoxical embolism with consequential transient ischemic attacks (TIAs), 
cerebrovascular accidents (CVAs), and systemic emboli. These residual defects 
as well as Fontan fenestrations should be occluded by transcatheter techniques 
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to return O2 saturations to normal and decrease the likelihood for paradoxical 
embolism [30, 32, 33, 83, 88, 89]. Amplatzer septal occluder (St. Jude Medical, 
Inc., St Paul, MN) is currently most common device used to accomplish this 
(Figures 7, 8, and 10). Tubular fenestrations may be closed with Amplatzer 
vascular plug devices (St. Jude Medical, Inc.) (Figure 9). Test occlusion of the 
residual defect or fenestration is suggested to ensure that adequate cardiac output 
is maintained following defect occlusion [89, 90], especially if the procedure is 
performed shortly after fenestrated Fontan. Late follow-up results of fenestration 
closure are good [33].
6.4 Thrombus formation
There is a tendency for thrombus formation in the Fontan pathway; the reported 
prevalence was 15–30% [91, 92]. Regrettably the usual transthoracic echo-Doppler 
Figure 11. 
Selected frames from cineangiograms of the pulmonary artery in posteroanterior view illustrating normal right 
pulmonary artery (RPA) and narrowed (arrow) left pulmonary artery (LPA) prior to (a) and after (b) stent 
(arrow) placement in an adolescent who had Fontan surgery several years earlier (Reproduced from [88]).
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evaluation may not discover these thrombi. However, transesophageal echocardiog-
raphy, MRI, or CT studies may be necessary to detect these thrombi. In an attempt 
to prevent thrombus formation in the Fontan circuit, thromboprophylaxis is 
commonly recommended; both warfarin and aspirin have been utilized in the past 
for this purpose. A multicenter, randomized trial was conducted to compare the 
efficacy of these two drugs; results showed less than optimal results with both drugs 
and no significant difference between the two regimens [93]. In the author’s experi-
ence, most children are prescribed with aspirin for thromboprophylaxis which may 
be switched to clopidogrel (Plavix) as the children approach adulthood.
Despite seemingly adequate thromboprophylaxis, some patients develop throm-
bosis of the Fontan conduits (Figure 12A). We initially employ thrombus dissolving 
drug therapy (tPA, heparin, etc.). If the thrombi do not resolve, we have employed 
stenting of the conduit to compress the thrombi against the conduit wall [94]. An 
example from our experience is shown in Figure 12.
6.5 Development of collateral vessels
Systemic venous to pulmonary venous and systemic arterial to pulmonary 
 arterial collateral vessels may develop in some patients after the Fontan procedure 
[88, 95]. These may develop both shortly after the procedure and during late follow-
up. Systemic venous to pulmonary venous collateral vessels produce arterial hypox-
emia. In addition, they may also become potential sites for paradoxical embolism. 
Figure 12. 
(A) Selected frame from a cineangiogram of a Fontan conduit in lateral view, illustrating a thrombus (arrow in 
(A)). (B) and (C) position of a stent (St) before (B) and after (C) its complete expansion. (D) Cineangiographic 
frame demonstrating the widely patent stent after stent deployment. Also, note the residual shunt (RS) at the 
superior aspect of the conduit (seen in (A) and (D)). The RS was occluded with an Amplatzer septal occluder 
device (AD) shortly after the cine shown in (D). (F) A follow-up cineangiogram 1 year later shows the continued 
patency of the conduit with no RS. TEE, transesophageal echo probe (Reproduced from [94]).
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Systemic arterial to pulmonary arterial (or venous) collateral vessels produce left 
ventricular volume overload. These abnormal vessels should be transcatheter-
occluded with coils, vascular plugs, and ductal occluding devices depending upon 
the size and accessibility. Examples from the author’s experience of occluding these 
vessels are shown in Figures 13–16 [88, 95, 96].
6.6 Protein loosing enteropathy
Protein losing enteropathy (PLE) is a grave long-term complication of Fontan 
with a prevalence of 11.1% in older types of Fontan [85, 97]. However, the incidence 
appears to have come down to 1.2% with staged TCPC [85, 98]. The reason for 
development of PLE is not understood. Intestinal protein loss secondary to lym-
phatic distension which in turn may be due to elevated pressure in systemic veins is 
considered to be a pathogenic mechanism. But, PLE has been seen even in patients 
with “normal” Fontan circuit pressures. Therefore, the true cause of PLE remains 
a mystery. The symptoms and signs of PLE are diarrhea, edema, ascites, and/or 
pleural effusions. Laboratory abnormalities include reduced serum albumin and 
elevated fecal alpha-1 antitrypsin levels. The PLE diagnosis may be confirmed with 
technetium 99m-labeled human serum albumin scintigraphy [99].
Because of high mortality rate seen with PLE, speedy diagnosis and implement-
ing aggressive management strategies are important [85]. At first, supportive 
therapy such as medium-chain triglycerides diet, infusion of intravenous albumin, 
and replacement of immunoglobulins should be undertaken. Obstructive lesions in 
the Fontan pathway should be scrutinized, and aortopulmonary connections should 
be screened for. If identified, they should be treated with appropriate transcatheter 
measures. Surgical therapy is indicated if they cannot be adequately addressed 
with transcatheter intervention. A variety of other treatment regimens, including 
prednisone, elementary diet, calcium replacement, regular high-molecular-weight 
heparin, low-molecular-weight heparin, somatostatin, high-dose spironolactone, 
sildenafil, and resection of localized intestinal lymphangiectasia, have been utilized 
in the past with varying degrees of success [85].
Figure 13. 
(a) Selected frame from a left innominate vein (L inn) cineangiogram in posteroanterior view demonstrating 
an anomalous vein (AV) opacifying the atrial mass (not marked). (b) Following occlusion with Gianturco coil 
(arrow), the AV is completely occluded and the systemic arterial saturation improved (Reproduced from [88]).
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Figure 14. 
(A) Selected frame from a cineangiogram in lateral view with the catheter positioned at the superior vena 
cava/azygos junction illustrating a fistula which results in opacification of the left atrium (LA). (B) The 
fistula was occluded with an Amplatzer vascular plug (arrow—AVP) with some residual flow. (C) Follow-up 
SVC injection shows complete occlusion by the AVP (Reproduced from [96]).
Figure 15. 
(A) Selected cine frame from an internal mammary artery (IMA) cineangiogram in the lateral view, 
demonstrating multiple small collateral vessels arising from the pericardiophrenic (PCP) branch, which 
resulted in a significant levophase (not shown). (B) Following occlusion with a Gianturco coil (C), there is 
complete occlusion of this vessel (Reproduced from [95]).
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Following a short trial of any of the above treatment modes, largely on the 
basis of the cardiologist’s preference, a more definitive treatment methods such as 
lessening the conduit pressure by creating a fenestration between the conduit and 
the atrium [99–101], converting atriopulmonary type of Fontan to TCPC [87, 102, 
103], instituting sequential atrioventricular pacing [104, 105], and performing 
cardiac transplantation [106–108] should all be considered. Again, it is essential to 
emphasize that timely treatment should be instituted as soon as PLE is identified 
[85]. Fortunately, the need for use of these methods has progressively diminished 
since the wide use of staged TCPC.
7. Summary and conclusions
Since the initial description of the Fontan operation in the early 1970s by Fontan, 
Kruetzer, and their associates, several modifications have been introduced. These 
include avoiding classic Glenn anastomosis; not using a prosthetic valve in the IVC; 
RA-PA anastomosis, direct or through a non-valved conduit; RA-PA anastomosis 
through a valved conduit; RA-RV anastomosis, direct or non-valved anastomosis; 
RA-RV anastomosis through a valved conduit; bidirectional Glenn procedure 
(cavopulmonary anastomosis); lateral tunnel; total cavopulmonary connection; 
extra-cardiac conduit, staged Fontan; fenestrated Fontan; and closure of Fontan 
fenestration. Currently staged, total cavopulmonary connection with extra-cardiac 
conduit and fenestration has become the most commonly used multistage surgery 
in accomplishing the Fontan.
The indications for Fontan are patients who have one functioning ventricle, and 
these include tricuspid atresia, double-inlet left ventricle, HLHS, mitral atresia with 
normal aortic root, unbalanced AVSDs, pulmonary atresia with intact ventricular 
Figure 16. 
(A) Selected cine frame from a right subclavian artery (RSA) cineangiogram showing branches (white arrows) 
of the thyrocervical (TC) trunk which supplied a number of small vessels, giving a good degree of levophase. 
(B) Complete occlusion occurred following the implantation of a Gianturco coil (C) (Reproduced from [95]).
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septum with markedly hypoplastic right ventricle, and other complex heart defects 
with one functioning ventricle. Recently there has been a trend for biventricular 
repair, particularly for patients with unbalanced AVSDs.
Stage I consists of performing palliative procedures on the basis of 
pathophysiology of the defect complex at presentation, usually in the neonatal 
period. Stage II involves performing a bidirectional Glenn procedure (diversion 
of the superior vena caval blood flow into both lungs) usually at about the age of 
6 months. During stage IIIA diversion of the IVC blood flow into the lungs, usually 
by an extra-cardiac conduit plus a fenestration, usually at about the age of 2 years. 
Stage IIIB consists of transcatheter closure of the fenestration 6–12 months after 
Stage IIIA.
Both the immediate and follow-up results have remarkably improved, both in 
terms of mortality and morbidity, following the introduction of staged total cavo-
pulmonary connection with extra-cardiac conduit and fenestration with subsequent 
catheter closure of Fontan fenestration. Complications do occur during follow-up, 
and they should be addressed as and when they are detected.
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